Skip to main content

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Assessing Anticholinergic Burden

August 5, 2025

HMP · Assessing Anticholinergic Burden

Chelsie Monroe, APN, PMHNP-BC explores anticholinergic burden and how to measure its cognitive impact in clinical care.

Related Content

Patient Concerns About Deprescribing: How to Address Them
Anticholinergic Misuse: Can These Medications Be Addictive?
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
Why Should We Deprescribe Anticholinergics?
What’s the Role of Amantadine in Anticholinergic Deprescription?
Treatment Options and Managing Side Effects in Schizophrenia
Assessing Anticholinergic Burden
© 2026 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy